Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393560 · ClinicalTrials.gov registry record
DECT Study in Allopurinol-Treated Gout Patients
A clinical trial, sponsored by Ardea Biosciences.
- Completed
- Registry status
- 223
- Enrollment target
NCT02393560 is a clinical trial that has completed, run by Ardea Biosciences. The registered enrollment target is 223 participants.
The verdict
NCT02393560 has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- 223 participants
- Enrollment target
Study Summary
The purpose of this study is to determine presence and volume of monosodium urate (MSU) crystal deposits as determined by dual-energy computed tomography (DECT) imaging in gout subjects treated with allopurinol with and without visible tophi.
Interventions
- PROCEDURE DECT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02393560
The ClinicalTrials.gov registry entry for NCT02393560 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DECT scan is the first listed.
NCT02393560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02393560 about?
NCT02393560 is a clinical study titled "DECT Study in Allopurinol-Treated Gout Patients". The purpose of this study is to determine presence and volume of monosodium urate (MSU) crystal deposits as determined by dual-energy computed tomography (DECT) imaging in gout subjects treated with allopurinol with and without visible tophi.
What is the current status of trial NCT02393560?
This trial is currently completed. The enrollment target is 223 participants. The study started on 2015-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02393560?
The interventions under investigation include: DECT scan (PROCEDURE).
Who is sponsoring clinical trial NCT02393560?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.